Leucotrovir - Leucovorin Calcium (Calcium Folinate)

Leucotrovir – Leucovorin Calcium (Calcium Folinate)

Leucovorin Calcium (Calcium Folinate) 50 mg / 5 mL

Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia

Leucotrovir contains Leucovorin Calcium (Calcium Folinate), a folate analog used to reduce the toxic effects of certain chemotherapy medicines, enhance the effectiveness of fluorouracil-based cancer treatment, and manage folate deficiency. It plays an important role in supportive oncology care and established chemotherapy protocols.

Contain

Leucovorin Calcium (Calcium Folinate) 50 mg / 5 mL

Strength

50 mg / 5 mL

Packaging

Vial

Category

Categories:

Manufacturer

Baker & Davis Private Limited

Brand

Leucotrovir

SEND US A MESSAGE

    CONTACT INFORMATION

    501, EAST BAY, BAYVUE, DR M B VELKAR MARG,
    KALBADEVI, MUMBAI-400002.

    +91 96531 13180

    sales@vinixbiopharma.com

    Do you have questions about how we can help your company? Send us an email and we’ll get in touch shortly.

    Product Overview

    Leucotrovir contains Leucovorin Calcium (Calcium Folinate), a reduced form of folic acid widely used in oncology and supportive care. It is commonly administered to help reduce the toxic effects associated with high-dose Methotrexate therapy and to enhance the therapeutic activity of fluorouracil (5-FU) in the treatment of certain cancers. Owing to its established clinical benefits, Leucovorin Calcium has become an integral component of modern chemotherapy protocols and supportive cancer care.

    Leucotrovir is used under the supervision of qualified healthcare professionals in hospitals, oncology centers, and specialized treatment facilities. It plays a significant role in improving treatment tolerability while supporting the effectiveness of selected chemotherapy regimens. In addition to its oncology applications, Leucovorin Calcium may also be used in the management of folate deficiency when clinically appropriate.


    How It Works

    Leucovorin Calcium is the active form of folic acid and does not require metabolic activation. It helps protect healthy cells from the harmful effects of folate antagonist medications such as Methotrexate by restoring folate-dependent cellular functions. When administered with fluorouracil (5-FU), it enhances the binding of the drug to its target enzyme, thereby increasing its anticancer activity and improving therapeutic effectiveness.


    Therapeutic Applications

    Leucotrovir may be prescribed as part of treatment protocols for:

    • High-Dose Methotrexate Rescue Therapy
    • Colorectal Cancer (in combination with Fluorouracil)
    • Gastric Cancer
    • Other gastrointestinal malignancies
    • Folate Deficiency
    • Supportive Oncology Care
    • Other indications as determined by the treating physician

    The medicine is frequently incorporated into combination chemotherapy regimens to optimize treatment outcomes and reduce therapy-related toxicity.


    Key Benefits

    • Reduced folate formulation for supportive oncology care.
    • Helps reduce Methotrexate-induced toxicity.
    • Enhances the effectiveness of Fluorouracil (5-FU) therapy.
    • Supports established chemotherapy treatment protocols.
    • Suitable for use in combination cancer therapy.
    • Manufactured under stringent pharmaceutical quality standards.

    Quality Commitment

    Vinix Biopharma is committed to delivering high-quality pharmaceutical products that meet stringent industry standards. Leucotrovir is manufactured under controlled production environments and undergoes rigorous quality assurance procedures to ensure safety, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support effective patient care.


    Storage Information

    Store according to the instructions provided on the product label. Protect from excessive heat, moisture, and direct sunlight. Keep out of reach of children.


    Disclaimer

    Leucotrovir should be administered only under the supervision of qualified healthcare professionals. Dosage and administration should be determined by the treating physician based on the patient’s medical condition, treatment protocol, and approved clinical guidelines.